Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  • A. Zer
  • , M. J. Ahn
  • , F. Barlesi
  • , L. Bubendorf
  • , D. De Ruysscher
  • , P. Garrido
  • , O. Gautschi
  • , L. E. Hendriks
  • , P. A. Jänne
  • , K. M. Kerr
  • , C. Mascaux
  • , T. Mitsudomi
  • , S. Peters
  • , C. Rolfo
  • , A. Sacher
  • , S. Senan
  • , P. Ugalde
  • , N. B. Leighl

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

•This ESMO Clinical Practice Guideline provides key recommendations for managing early and locally advanced NSCLC. •The guideline covers diagnosis, staging, risk assessment, treatment and follow-up. •Treatment algorithms for resectable and unresectable disease are provided. •The authors encompass a multidisciplinary group of experts from different institutions and countries. •Recommendations are based on available scientific data and the authors’ collective expert opinion.

Original languageEnglish
JournalAnnals of Oncology
DOIs
StateAccepted/In press - 2025

Keywords

  • diagnosis
  • early non-small-cell lung cancer (NSCLC)
  • guideline
  • staging
  • treatment

Fingerprint

Dive into the research topics of 'Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'. Together they form a unique fingerprint.

Cite this